Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan

Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan

Rheumatoid arthritis (RA) is a chronic inflammatory systemic disease characterized by persistent joint synovial inflammation and swelling, leading to cartilage damage and bone erosion. This retrospective, longitudinal study is to evaluate the treatment patterns of biologic-naïve RA patients receivin...

Full description

Bibliographic Details
Main Authors: Ko-Jen Li, Chia-Li Chang, Chih-Yi Hsin, Chao-Hsiun Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Pharmacology
Subjects:
biologic disease-modifying antirheumatic drug
treatment pattern
rheumatoid arthritis
tofacitinib
tumor necrosis factor inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.628548/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.628548/full

Similar Items